img

Global Insulin Like Growth Factor 1 Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Insulin Like Growth Factor 1 Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Insulin Like Growth Factor 1 Receptor report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insulin Like Growth Factor 1 Receptor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Insulin Like Growth Factor 1 Receptor industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insulin Like Growth Factor 1 Receptor key manufacturers include Astellas Pharma Inc., AstraZeneca Plc, Axelar AB, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genmab A/S and Immunomedics, Inc., etc. Astellas Pharma Inc., AstraZeneca Plc, Axelar AB are top 3 players and held % sales share in total in 2022.
Insulin Like Growth Factor 1 Receptor can be divided into BI-893923, CT-707, 1R-E1 and ATL-1101, etc. BI-893923 is the mainstream product in the market, accounting for % sales share globally in 2022.
Insulin Like Growth Factor 1 Receptor is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Insulin Like Growth Factor 1 Receptor industry development. In 2022, global % sales of Insulin Like Growth Factor 1 Receptor went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insulin Like Growth Factor 1 Receptor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Astellas Pharma Inc.
AstraZeneca Plc
Axelar AB
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Genmab A/S
Immunomedics, Inc.
Insmed Incorporated
Merck & Co., Inc.
Merrimack Pharmaceuticals, Inc.
Novartis AG
PharmAbcine, Inc.
ProteoThera, Inc.
Segment by Type
BI-893923
CT-707
1R-E1
ATL-1101
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insulin Like Growth Factor 1 Receptor market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insulin Like Growth Factor 1 Receptor, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insulin Like Growth Factor 1 Receptor industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insulin Like Growth Factor 1 Receptor in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insulin Like Growth Factor 1 Receptor introduction, etc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Insulin Like Growth Factor 1 Receptor market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Insulin Like Growth Factor 1 Receptor Market Overview
1.1 Insulin Like Growth Factor 1 Receptor Product Overview
1.2 Insulin Like Growth Factor 1 Receptor Market Segment by Type
1.2.1 BI-893923
1.2.2 CT-707
1.2.3 1R-E1
1.2.4 ATL-1101
1.2.5 Others
1.3 Global Insulin Like Growth Factor 1 Receptor Market Size by Type
1.3.1 Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Type (2018-2034)
1.3.2 Global Insulin Like Growth Factor 1 Receptor Historic Market Size Review by Type (2018-2024)
1.3.3 Global Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.2 Europe Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Breakdown by Type (2018-2024)
2 Global Insulin Like Growth Factor 1 Receptor Market Competition by Company
2.1 Global Top Players by Insulin Like Growth Factor 1 Receptor Sales (2018-2024)
2.2 Global Top Players by Insulin Like Growth Factor 1 Receptor Revenue (2018-2024)
2.3 Global Top Players by Insulin Like Growth Factor 1 Receptor Price (2018-2024)
2.4 Global Top Manufacturers Insulin Like Growth Factor 1 Receptor Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Like Growth Factor 1 Receptor Market Competitive Situation and Trends
2.5.1 Insulin Like Growth Factor 1 Receptor Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Like Growth Factor 1 Receptor Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Like Growth Factor 1 Receptor as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Like Growth Factor 1 Receptor Market
2.8 Key Manufacturers Insulin Like Growth Factor 1 Receptor Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Like Growth Factor 1 Receptor Status and Outlook by Region
3.1 Global Insulin Like Growth Factor 1 Receptor Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Insulin Like Growth Factor 1 Receptor Historic Market Size by Region
3.2.1 Global Insulin Like Growth Factor 1 Receptor Sales in Volume by Region (2018-2024)
3.2.2 Global Insulin Like Growth Factor 1 Receptor Sales in Value by Region (2018-2024)
3.2.3 Global Insulin Like Growth Factor 1 Receptor Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Region
3.3.1 Global Insulin Like Growth Factor 1 Receptor Sales in Volume by Region (2024-2034)
3.3.2 Global Insulin Like Growth Factor 1 Receptor Sales in Value by Region (2024-2034)
3.3.3 Global Insulin Like Growth Factor 1 Receptor Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Insulin Like Growth Factor 1 Receptor by Application
4.1 Insulin Like Growth Factor 1 Receptor Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Insulin Like Growth Factor 1 Receptor Market Size by Application
4.2.1 Global Insulin Like Growth Factor 1 Receptor Market Size Overview by Application (2018-2034)
4.2.2 Global Insulin Like Growth Factor 1 Receptor Historic Market Size Review by Application (2018-2024)
4.2.3 Global Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.2 Europe Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Breakdown by Application (2018-2024)
5 North America Insulin Like Growth Factor 1 Receptor by Country
5.1 North America Insulin Like Growth Factor 1 Receptor Historic Market Size by Country
5.1.1 North America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2018-2024)
5.1.3 North America Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2018-2024)
5.2 North America Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Country
5.2.1 North America Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2024-2034)
5.2.2 North America Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2024-2034)
6 Europe Insulin Like Growth Factor 1 Receptor by Country
6.1 Europe Insulin Like Growth Factor 1 Receptor Historic Market Size by Country
6.1.1 Europe Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2018-2024)
6.1.3 Europe Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2018-2024)
6.2 Europe Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Country
6.2.1 Europe Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2024-2034)
6.2.2 Europe Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2024-2034)
7 Asia-Pacific Insulin Like Growth Factor 1 Receptor by Region
7.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales in Value by Region (2024-2034)
8 Latin America Insulin Like Growth Factor 1 Receptor by Country
8.1 Latin America Insulin Like Growth Factor 1 Receptor Historic Market Size by Country
8.1.1 Latin America Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2018-2024)
8.1.3 Latin America Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2018-2024)
8.2 Latin America Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Country
8.2.1 Latin America Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2024-2034)
8.2.2 Latin America Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2024-2034)
9 Middle East and Africa Insulin Like Growth Factor 1 Receptor by Country
9.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Astellas Pharma Inc.
10.1.1 Astellas Pharma Inc. Company Information
10.1.2 Astellas Pharma Inc. Introduction and Business Overview
10.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Products Offered
10.1.5 Astellas Pharma Inc. Recent Development
10.2 AstraZeneca Plc
10.2.1 AstraZeneca Plc Company Information
10.2.2 AstraZeneca Plc Introduction and Business Overview
10.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Products Offered
10.2.5 AstraZeneca Plc Recent Development
10.3 Axelar AB
10.3.1 Axelar AB Company Information
10.3.2 Axelar AB Introduction and Business Overview
10.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Axelar AB Insulin Like Growth Factor 1 Receptor Products Offered
10.3.5 Axelar AB Recent Development
10.4 Boehringer Ingelheim GmbH
10.4.1 Boehringer Ingelheim GmbH Company Information
10.4.2 Boehringer Ingelheim GmbH Introduction and Business Overview
10.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Products Offered
10.4.5 Boehringer Ingelheim GmbH Recent Development
10.5 Bristol-Myers Squibb Company
10.5.1 Bristol-Myers Squibb Company Company Information
10.5.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Products Offered
10.5.5 Bristol-Myers Squibb Company Recent Development
10.6 Eli Lilly and Company
10.6.1 Eli Lilly and Company Company Information
10.6.2 Eli Lilly and Company Introduction and Business Overview
10.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Products Offered
10.6.5 Eli Lilly and Company Recent Development
10.7 F. Hoffmann-La Roche Ltd.
10.7.1 F. Hoffmann-La Roche Ltd. Company Information
10.7.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.7.4 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Products Offered
10.7.5 F. Hoffmann-La Roche Ltd. Recent Development
10.8 Genmab A/S
10.8.1 Genmab A/S Company Information
10.8.2 Genmab A/S Introduction and Business Overview
10.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Genmab A/S Insulin Like Growth Factor 1 Receptor Products Offered
10.8.5 Genmab A/S Recent Development
10.9 Immunomedics, Inc.
10.9.1 Immunomedics, Inc. Company Information
10.9.2 Immunomedics, Inc. Introduction and Business Overview
10.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Products Offered
10.9.5 Immunomedics, Inc. Recent Development
10.10 Insmed Incorporated
10.10.1 Insmed Incorporated Company Information
10.10.2 Insmed Incorporated Introduction and Business Overview
10.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Products Offered
10.10.5 Insmed Incorporated Recent Development
10.11 Merck & Co., Inc.
10.11.1 Merck & Co., Inc. Company Information
10.11.2 Merck & Co., Inc. Introduction and Business Overview
10.11.3 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Products Offered
10.11.5 Merck & Co., Inc. Recent Development
10.12 Merrimack Pharmaceuticals, Inc.
10.12.1 Merrimack Pharmaceuticals, Inc. Company Information
10.12.2 Merrimack Pharmaceuticals, Inc. Introduction and Business Overview
10.12.3 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Products Offered
10.12.5 Merrimack Pharmaceuticals, Inc. Recent Development
10.13 Novartis AG
10.13.1 Novartis AG Company Information
10.13.2 Novartis AG Introduction and Business Overview
10.13.3 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Novartis AG Insulin Like Growth Factor 1 Receptor Products Offered
10.13.5 Novartis AG Recent Development
10.14 PharmAbcine, Inc.
10.14.1 PharmAbcine, Inc. Company Information
10.14.2 PharmAbcine, Inc. Introduction and Business Overview
10.14.3 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.14.4 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Products Offered
10.14.5 PharmAbcine, Inc. Recent Development
10.15 ProteoThera, Inc.
10.15.1 ProteoThera, Inc. Company Information
10.15.2 ProteoThera, Inc. Introduction and Business Overview
10.15.3 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.15.4 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Products Offered
10.15.5 ProteoThera, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Like Growth Factor 1 Receptor Industrial Chain Analysis
11.4 Insulin Like Growth Factor 1 Receptor Market Dynamics
11.4.1 Insulin Like Growth Factor 1 Receptor Industry Trends
11.4.2 Insulin Like Growth Factor 1 Receptor Market Drivers
11.4.3 Insulin Like Growth Factor 1 Receptor Market Challenges
11.4.4 Insulin Like Growth Factor 1 Receptor Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Like Growth Factor 1 Receptor Distributors
12.3 Insulin Like Growth Factor 1 Receptor Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of BI-893923
Table 2. Major Company of CT-707
Table 3. Major Company of 1R-E1
Table 4. Major Company of ATL-1101
Table 5. Major Company of Others
Table 6. Global Insulin Like Growth Factor 1 Receptor Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (US& Million)
Table 10. Global Insulin Like Growth Factor 1 Receptor Market Share in Value by Type (2018-2024)
Table 11. Global Insulin Like Growth Factor 1 Receptor Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type (2024-2034)
Table 16. Global Insulin Like Growth Factor 1 Receptor Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Insulin Like Growth Factor 1 Receptor Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Insulin Like Growth Factor 1 Receptor Sales Share by Company (2018-2024)
Table 29. Global Insulin Like Growth Factor 1 Receptor Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Company (2018-2024)
Table 31. Global Market Insulin Like Growth Factor 1 Receptor Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Insulin Like Growth Factor 1 Receptor Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Insulin Like Growth Factor 1 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Like Growth Factor 1 Receptor as of 2022)
Table 35. Date of Key Manufacturers Enter into Insulin Like Growth Factor 1 Receptor Market
Table 36. Key Manufacturers Insulin Like Growth Factor 1 Receptor Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Insulin Like Growth Factor 1 Receptor Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Region (2018-2024)
Table 43. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Insulin Like Growth Factor 1 Receptor Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Region (2024-2034)
Table 48. Global Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Insulin Like Growth Factor 1 Receptor Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application (2018-2024)
Table 54. Global Insulin Like Growth Factor 1 Receptor Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application (2024-2034)
Table 59. Global Insulin Like Growth Factor 1 Receptor Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 61. North America Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 74. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Country (2024-2034)
Table 110. Astellas Pharma Inc. Company Information
Table 111. Astellas Pharma Inc. Introduction and Business Overview
Table 112. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product
Table 114. Astellas Pharma Inc. Recent Development
Table 115. AstraZeneca Plc Company Information
Table 116. AstraZeneca Plc Introduction and Business Overview
Table 117. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product
Table 119. AstraZeneca Plc Recent Development
Table 120. Axelar AB Company Information
Table 121. Axelar AB Introduction and Business Overview
Table 122. Axelar AB Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Axelar AB Insulin Like Growth Factor 1 Receptor Product
Table 124. Axelar AB Recent Development
Table 125. Boehringer Ingelheim GmbH Company Information
Table 126. Boehringer Ingelheim GmbH Introduction and Business Overview
Table 127. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product
Table 129. Boehringer Ingelheim GmbH Recent Development
Table 130. Bristol-Myers Squibb Company Company Information
Table 131. Bristol-Myers Squibb Company Introduction and Business Overview
Table 132. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product
Table 134. Bristol-Myers Squibb Company Recent Development
Table 135. Eli Lilly and Company Company Information
Table 136. Eli Lilly and Company Introduction and Business Overview
Table 137. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product
Table 139. Eli Lilly and Company Recent Development
Table 140. F. Hoffmann-La Roche Ltd. Company Information
Table 141. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 142. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product
Table 144. F. Hoffmann-La Roche Ltd. Recent Development
Table 145. Genmab A/S Company Information
Table 146. Genmab A/S Introduction and Business Overview
Table 147. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Genmab A/S Insulin Like Growth Factor 1 Receptor Product
Table 149. Genmab A/S Recent Development
Table 150. Immunomedics, Inc. Company Information
Table 151. Immunomedics, Inc. Introduction and Business Overview
Table 152. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product
Table 154. Immunomedics, Inc. Recent Development
Table 155. Insmed Incorporated Company Information
Table 156. Insmed Incorporated Introduction and Business Overview
Table 157. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product
Table 159. Insmed Incorporated Recent Development
Table 160. Merck & Co., Inc. Company Information
Table 161. Merck & Co., Inc. Introduction and Business Overview
Table 162. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 163. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product
Table 164. Merck & Co., Inc. Recent Development
Table 165. Merrimack Pharmaceuticals, Inc. Company Information
Table 166. Merrimack Pharmaceuticals, Inc. Introduction and Business Overview
Table 167. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 168. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product
Table 169. Merrimack Pharmaceuticals, Inc. Recent Development
Table 170. Novartis AG Company Information
Table 171. Novartis AG Introduction and Business Overview
Table 172. Novartis AG Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 173. Novartis AG Insulin Like Growth Factor 1 Receptor Product
Table 174. Novartis AG Recent Development
Table 175. PharmAbcine, Inc. Company Information
Table 176. PharmAbcine, Inc. Introduction and Business Overview
Table 177. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 178. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product
Table 179. PharmAbcine, Inc. Recent Development
Table 180. ProteoThera, Inc. Company Information
Table 181. ProteoThera, Inc. Introduction and Business Overview
Table 182. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 183. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product
Table 184. ProteoThera, Inc. Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Insulin Like Growth Factor 1 Receptor Market Trends
Table 188. Insulin Like Growth Factor 1 Receptor Market Drivers
Table 189. Insulin Like Growth Factor 1 Receptor Market Challenges
Table 190. Insulin Like Growth Factor 1 Receptor Market Restraints
Table 191. Insulin Like Growth Factor 1 Receptor Distributors List
Table 192. Insulin Like Growth Factor 1 Receptor Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Like Growth Factor 1 Receptor Product Picture
Figure 2. Global Insulin Like Growth Factor 1 Receptor Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Insulin Like Growth Factor 1 Receptor Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Insulin Like Growth Factor 1 Receptor Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of BI-893923
Figure 6. Global BI-893923 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of CT-707
Figure 8. Global CT-707 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of 1R-E1
Figure 10. Global 1R-E1 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of ATL-1101
Figure 12. Global ATL-1101 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Type in 2022 & 2034
Figure 17. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 18. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2022
Figure 19. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 20. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2022
Figure 23. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Like Growth Factor 1 Receptor Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Like Growth Factor 1 Receptor Revenue in 2022
Figure 29. Insulin Like Growth Factor 1 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Clinic
Figure 33. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2022 & 2034
Figure 38. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 39. North America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2022
Figure 40. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 41. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2022
Figure 44. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Insulin Like Growth Factor 1 Receptor Manufacturing Cost Structure
Figure 49. Insulin Like Growth Factor 1 Receptor Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries